“Reversi-Type Virologic Failure” Involved in the Development of NS5A-RAVs in Patients with Genotype 1b HCV Carrying No Signature RAVs at Baseline

enthalten in: Hepatology research | 2017

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

“Reversi‐type virologic failure” involved in the development of non‐structural protein 5A resistance‐associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline

enthalten in: Hepatology research | 2017

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism

enthalten in: Hepatology research | 2016

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient

enthalten in: Hepatology research | 2014

von Uchida, Y. | Kouyama, J. | Naiki, K. | +4